Source Publication

Brain Research

Document Type

Article

Publication Date

2-1992

DOI

https://doi.org/10.1016/0006-8993(92)90784-7

Abstract

The mammalian circadian clock in the suprachiasmatic nuclei (SCN) can be phase-shifted in vitro by the serotonin agonist quipazine. Here we show that quipazine resets the SCN clock in the presence of tetrodotoxin or 10 mM Mg2+, treatments that block Na+ action potentials and Ca2+ channels, respectively. These results support the hypothesis that quipazine resets the clock by stimulating receptors located on clock elements rather than on cells afferent to the clock.

Submission Type

Publisher's Version

Files over 3MB may be slow to open. For best results, right-click and select "save as..."

Share

COinS